Your browser doesn't support javascript.
loading
[FALSE POSITIVE 5-ALA INDUCED FLUORESCENCE OF HEMATOLOGICAL MALIGNANCIES, BENIGN TUMORS, INFECTIOUS AND INFLAMMATORY PATHOLOGIES PRESENTED AS BRAIN LESIONS - A CASE SERIES].
Doron, Omer; Paldor, Iddo.
Afiliación
  • Doron O; The Department of Neurosurgery, Rambam (Maimonides) Health Care Campus, Haifa, Israel, Biomedical Engineering Department, The Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
  • Paldor I; The Department of Neurosurgery, Rambam (Maimonides) Health Care Campus, Haifa, Israel, The Faculty of Medicine - the Technion - Israeli Institute of Technology.
Harefuah ; 162(4): 216-220, 2023 Apr.
Article en He | MEDLINE | ID: mdl-37120740
INTRODUCTION: The 5-aminolevulinic acid (5-ALA) fluorescence-guided resection is an essential part of the current state-of-the-art treatment of primary malignant brain tumors. Metabolized by tumor cells, creating Protoporphyrin-IX, which is fluorescent under UV light emitted from the microscope, 5-ALA facilitates visual distinction between the tumor and the normal brain tissue surrounding it, coloring it pink. This real-time diagnostic feature was shown to lead to more complete removal of the tumor and confers a survival benefit. Nevertheless, despite the high sensitivity and specificity that was described using this method, there are other pathological processes in which 5-ALA is being metabolized that fluoresce similarly to a malignant glial tumor.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias Hematológicas / Glioma Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: He Revista: Harefuah Año: 2023 Tipo del documento: Article País de afiliación: Israel
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias Hematológicas / Glioma Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: He Revista: Harefuah Año: 2023 Tipo del documento: Article País de afiliación: Israel